These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 18946496

  • 1. Re-targeted adenovirus vectors with dual specificity; binding specificities conferred by two different Affibody molecules in the fiber.
    Myhre S, Henning P, Friedman M, Ståhl S, Lindholm L, Magnusson MK.
    Gene Ther; 2009 Feb; 16(2):252-61. PubMed ID: 18946496
    [Abstract] [Full Text] [Related]

  • 2. Adenovirus 5 vector genetically re-targeted by an Affibody molecule with specificity for tumor antigen HER2/neu.
    Magnusson MK, Henning P, Myhre S, Wikman M, Uil TG, Friedman M, Andersson KM, Hong SS, Hoeben RC, Habib NA, Ståhl S, Boulanger P, Lindholm L.
    Cancer Gene Ther; 2007 May; 14(5):468-79. PubMed ID: 17273181
    [Abstract] [Full Text] [Related]

  • 3. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob.
    Mizuguchi H, Koizumi N, Hosono T, Utoguchi N, Watanabe Y, Kay MA, Hayakawa T.
    Gene Ther; 2001 May; 8(9):730-5. PubMed ID: 11406768
    [Abstract] [Full Text] [Related]

  • 4. Generation and selection of targeted adenoviruses embodying optimized vector properties.
    Noureddini SC, Krendelshchikov A, Simonenko V, Hedley SJ, Douglas JT, Curiel DT, Korokhov N.
    Virus Res; 2006 Mar; 116(1-2):185-95. PubMed ID: 16293334
    [Abstract] [Full Text] [Related]

  • 5. Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies.
    Rittner K, Schreiber V, Erbs P, Lusky M.
    Cancer Gene Ther; 2007 May; 14(5):509-18. PubMed ID: 17318198
    [Abstract] [Full Text] [Related]

  • 6. Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.
    Kuhlmann KF, van Geer MA, Bakker CT, Dekker JE, Havenga MJ, Elferink RP, Gouma DJ, Bosma PJ, Wesseling JG.
    Cancer Gene Ther; 2009 Jul; 16(7):585-97. PubMed ID: 19180144
    [Abstract] [Full Text] [Related]

  • 7. Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector.
    Myhre S, Henning P, Granio O, Tylö AS, Nygren PA, Olofsson S, Boulanger P, Lindholm L, Hong SS.
    Gene Ther; 2007 Feb; 14(4):376-81. PubMed ID: 17036056
    [Abstract] [Full Text] [Related]

  • 8. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
    Hoffmann D, Meyer B, Wildner O.
    J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
    [Abstract] [Full Text] [Related]

  • 9. Targeting adenovirus.
    Wickham TJ.
    Gene Ther; 2000 Jan; 7(2):110-4. PubMed ID: 10673715
    [Abstract] [Full Text] [Related]

  • 10. Biophysical targeting of adenovirus vectors for gene therapy.
    Silman NJ, Fooks AR.
    Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755
    [Abstract] [Full Text] [Related]

  • 11. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.
    Wesseling JG, Bosma PJ, Krasnykh V, Kashentseva EA, Blackwell JL, Reynolds PN, Li H, Parameshwar M, Vickers SM, Jaffee EM, Huibregtse K, Curiel DT, Dmitriev I.
    Gene Ther; 2001 Jul; 8(13):969-76. PubMed ID: 11438831
    [Abstract] [Full Text] [Related]

  • 12. Fiber-modified adenoviruses for targeted gene therapy.
    Wu H, Curiel DT.
    Methods Mol Biol; 2008 Jul; 434():113-32. PubMed ID: 18470642
    [Abstract] [Full Text] [Related]

  • 13. Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability.
    Magnusson MK, Hong SS, Henning P, Boulanger P, Lindholm L.
    J Gene Med; 2002 Jul; 4(4):356-70. PubMed ID: 12124978
    [Abstract] [Full Text] [Related]

  • 14. Novel adenoviral gene delivery system targeted against head and neck cancer.
    Li D, Guang W, Abuzeid WM, Roy S, Gao GP, Sauk JJ, O'Malley BW.
    Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
    [Abstract] [Full Text] [Related]

  • 15. Addition of a short peptide ligand to the adenovirus fiber protein.
    Michael SI, Hong JS, Curiel DT, Engler JA.
    Gene Ther; 1995 Nov; 2(9):660-8. PubMed ID: 8548556
    [Abstract] [Full Text] [Related]

  • 16. Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus.
    Nicklin SA, Von Seggern DJ, Work LM, Pek DC, Dominiczak AF, Nemerow GR, Baker AH.
    Mol Ther; 2001 Dec; 4(6):534-42. PubMed ID: 11735337
    [Abstract] [Full Text] [Related]

  • 17. Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob.
    Miura Y, Yoshida K, Nishimoto T, Hatanaka K, Ohnami S, Asaka M, Douglas JT, Curiel DT, Yoshida T, Aoki K.
    Gene Ther; 2007 Oct; 14(20):1448-60. PubMed ID: 17700705
    [Abstract] [Full Text] [Related]

  • 18. Recombinant adenovirus vectors with knobless fibers for targeted gene transfer.
    van Beusechem VW, van Rijswijk AL, van Es HH, Haisma HJ, Pinedo HM, Gerritsen WR.
    Gene Ther; 2000 Nov; 7(22):1940-6. PubMed ID: 11127582
    [Abstract] [Full Text] [Related]

  • 19. Targeting of adenoviral vectors through a bispecific single-chain antibody.
    Haisma HJ, Grill J, Curiel DT, Hoogeland S, van Beusechem VW, Pinedo HM, Gerritsen WR.
    Cancer Gene Ther; 2000 Jun; 7(6):901-4. PubMed ID: 10880021
    [Abstract] [Full Text] [Related]

  • 20. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
    Zheng S, Ulasov IV, Han Y, Tyler MA, Zhu ZB, Lesniak MS.
    J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.